Lockheed Martin Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-17,400
Closed -$1.31M 106
2018
Q1
$1.31M Buy
17,400
+12,400
+248% +$986K 0.05% 83
2017
Q4
$358K Buy
5,000
+1,000
+25% +$75.9K 0.02% 122
2017
Q3
$324K Buy
+4,000
New +$306K 0.02% 130
2017
Q2
Sell
-19,250
Closed -$1.31M 132
2017
Q1
$1.31M Hold
19,250
0.07% 99
2016
Q4
$1.38M Hold
19,250
0.12% 81
2016
Q3
$1.52M Hold
19,250
0.13% 88
2016
Q2
$1.61M Buy
19,250
+9,000
+88% +$799K 0.16% 79
2016
Q1
$942K Hold
10,250
0.09% 62
2015
Q4
$1.04M Hold
10,250
0.1% 58
2015
Q3
$1.01M Hold
10,250
0.11% 67
2015
Q2
$1.2M Buy
+10,250
New +$1.12M 0.06% 86
2015
Q1
Sell
-50,500
Closed -$4.76M 140
2014
Q4
$4.76M Sell
50,500
-23,500
-32% -$2.43M 0.2% 36
2014
Q3
$7.88M Buy
74,000
+15,000
+25% +$1.47M 0.36% 31
2014
Q2
$4.89M Sell
59,000
-48,000
-45% -$3.74M 0.22% 44
2014
Q1
$7.58M Sell
107,000
-54,000
-34% -$4.24M 0.39% 43
2013
Q4
$12.1M Buy
161,000
+121,000
+303% +$8.43M 0.67% 30
2013
Q3
$2.52M Buy
+40,000
New +$2.39M 0.14% 68

Other funds holding GILD

Lockheed Martin Investment Management's GILD Position: Q2 2018 in Review

Lockheed Martin Investment Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 17,400 shares — an estimated $1.31M sold.

Lockheed Martin Investment Management first reported a position in GILD in Q3 2013 and held it in 17 quarters. The position peaked at $12.1M in Q4 2013. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Lockheed Martin Investment Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 17,400 Gilead Sciences shares in Q2 2018, an estimated $1.31M.
  • Lockheed Martin Investment Management first reported a position in Gilead Sciences in Q3 2013 and held it in 17 quarters.
  • Lockheed Martin Investment Management's Gilead Sciences position peaked at $12.1M in Q4 2013.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.